Q2 2025 Holdings
Filed 2025-08-14 | 76 holdings | $362.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $34.5M | 415,505 | 9.5% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $29.0M | 13,680,554 | 8.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $24.9M | 677,176 | 6.9% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $21.6M | 168,763 | 6.0% |
| Merus BV | COM | N5749R100 | $21.0M | 398,804 | 5.8% |
| Atricure Inc(ATRC) | COM | 04963C209 | $19.4M | 592,273 | 5.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.2M | 398,100 | 3.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $13.0M | 619,090 | 3.6% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $13.0M | 102,500 | 3.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $12.5M | 72,677 | 3.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $9.0M | 287,939 | 2.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.9M | 70,615 | 2.5% |
| Axogen Inc(AXGN) | COM | 05463X106 | $8.0M | 741,782 | 2.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.6M | 581,757 | 1.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.7M | 65,552 | 1.6% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $5.7M | 879,163 | 1.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $5.7M | 501,972 | 1.6% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $5.5M | 294,208 | 1.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $5.1M | 627,626 | 1.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.1M | 543,602 | 1.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $5.0M | 371,523 | 1.4% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $5.0M | $4,000,000 | 1.4% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.8M | 349,515 | 1.3% |
| Inogen Inc(INGN) | COM | 45780L104 | $4.3M | 605,625 | 1.2% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.6M | 130,175 | 1.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $3.3M | 235,235 | 0.9% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $3.2M | 1,567,561 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.1M | 238,140 | 0.9% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.1M | 9,900 | 0.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $3.1M | 191,493 | 0.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.0M | 103,748 | 0.8% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $2.9M | 317,001 | 0.8% |
| Tela BIO Inc(TELA) | COM | 872381108 | $2.8M | 1,441,029 | 0.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.7M | 463,368 | 0.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $2.4M | 168,500 | 0.7% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $2.3M | 811,046 | 0.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $2.1M | 11,000 | 0.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.0M | 218,255 | 0.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $1.7M | 324,775 | 0.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.7M | 130,316 | 0.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.7M | 64,516 | 0.5% |
| Accuray Inc(ARAY) | COM | 004397105 | $1.7M | 1,222,358 | 0.5% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $1.7M | 127,151 | 0.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $1.6M | 1,380,118 | 0.4% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $1.5M | 378,083 | 0.4% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.4M | 300,452 | 0.4% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.4M | 140,847 | 0.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.4M | 135,271 | 0.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $1.4M | 526,660 | 0.4% |
| Immatics NV(IMTX) | SHS | N44445109 | $1.3M | 245,000 | 0.4% |